Tanios S. Bekaii-Saab, David Cosgrove, Ila Sruti, Junxin Shi, Wei Dai, Gregory Alan Patton, Sreevalsa Appukkuttan, Brian Thomas Hocum, Arvind Katta, Jacob Earl, Svetlana Babajanyan, Afsaneh Barzi. "Real-world (RW) treatment patterns and clinical outcomes of patients treated with sequential regorafenib and trifluridine/tipiracil ± bevacizumab (BEV) for metastatic colorectal cancer (mCRC) in the United States (US) community oncology setting: The SEQRT2 study.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.4_suppl.62